Cite
HARVARD Citation
Sekino, Y. et al. (2019). Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients. Prostate. 79 (2), pp. 234-242. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sekino, Y. et al. (2019). Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients. Prostate. 79 (2), pp. 234-242. [Online].